NEW YORK, March 26 - LumiCyte of Fremont, Calif. has obtained $20 million in private venture capital to fund its protein biochip program, the company said Monday.

The financing round, which follows the company's initial $5 million fundraising effort last year, was led by Tullis-Dickerson & Co., with additional funding from OrbiMed Advisors and Redleaf Group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.